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Abstract 
A cerebrovascular accident occurs in less than 24 hours resulting in chronic physical and 
cognitive deficits. However, little is known about how a cerebrovascular accident impacts the 
individual’s activities of daily living (ADL). This study sought to compare and analyze the 
impact of two therapeutic devices on patients’ responses to ADL questionnaire items from 
baseline to 6 months. It was hypothesized that the Functional Electrical Stimulation (FES) would 
be more effective and have a greater positive impact on patients’ response of ADL items than the 
AFO brace. In this study, subjects’ responses were recorded on the Stroke Impact Scale 
questionnaire (SIS) that contained eight sections. Subjects’ responses were later assessed by 
calculating the average from each section, which was then summed up by adding all the averaged 
scores for a total score. Overall, the results were centered around time and treatment in a 2 by 2 
mixed ANOVA. The independent variables were time and treatment with the dependent 
variables being the eight sections from the SIS with the focus on the ADL section. A primary 
limitation is the SIS is a unilateral questionnaire only administered to the subjects who have 
experienced a stroke thus providing a subjective view of the responses. The FES device was 
found to be neither inferior nor superior to the AFO brace and the results did not support the 
hypothesis. 
Keywords: Psychology, Cerebrovascular Accident, Therapeutic devices, FES, Functional 
Electrical Stimulation, AFO, Ankle Foot Orthosis, The Stroke Impact Scale, SIS, Activities of 
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The Comparison of Utilizing Functional Electrical Stimulation Device Versus Ankle Foot 
Orthosis Brace and the Effect on Participants’ Activities of Daily Living after a 
Cerebrovascular Accident 
A cerebrovascular accident (CVA) can be defined as “a transient episode of neurological 
dysfunctions caused by focal brain, spinal cord, or retinal ischemia, without acute infarction” 
(Coupland, et al., 2017).  In other words, a CVA occurs in a short amount of time - less than 24 
hours- yet can result in chronic physical, cognitive, and psychosocial deficits. It is suggested that 
15 million people worldwide suffer from a CVA every year, of which 5 million become disabled 
(Sabut et al., 2011). Since numerous individuals have been, and continue to be, affected by 
CVAs, it’s important to determine what effect a CVA has on performance of everyday tasks, as 
defined by activities of daily living (ADLs), in order to develop new therapeutic interventions.   
Background of Cerebrovascular Accident 
There are two types of CVA; ischemic and hemorrhagic. An ischemic CVA, 
accounting for 83% of diagnosed CVAs, is due to a blockage preventing blood flow and oxygen 
intake in the brain (Taylor, 2008). A hemorrhagic CVA, accounting for 17% of CVAs, is the 
rupture of an aneurysm. An aneurysm is a weakening in the wall of the blood vessel that expands 
outwards. Eventually, the wall becomes too thin and ruptures, releasing large amounts of blood 
into the brain (Taylor, 2008).  In both cases, neurons begin to die, which can result in motor and 
cognitive deficits. These deficits can affect an individuals’ quality of life; shown by the lack of 
ability to participate in everyday tasks and engage in social interactions (Lai, Studenski, Duncan, 
& Perera, 2002).  There have been many advancements in recovery, like clinical therapeutic 
programs, in order to help individuals cope with the physical and cognitive deficits that may 
result from a CVA. However, there is currently no clinical procedure to prevent a CVA, only 
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precautionary measures to minimize the occurrence of a CVA (Mayo, Wood-Dauphinee, Cote, 
Durcan, &Carlton, 2002). Some preventive measures include: early usage of aspirin, monitoring 
blood pressure and glycemic control, following a heart healthy diet, and a consistent exercise 
regimen (Gurol and Kim, 2018). 
Physical Deficits resulting from a CVA 
The physical deficits of a CVA can include hemiplegia, foot drop, and spasticity. 
Hemiplegia is when one side of the body is paralyzed contralateral to the lesion (Taylor, 2008). 
In other words, if the right side of the brain has a CVA, the left side of the body is affected and 
vice versa.  When the individual is hemiplegic, the individual could experience the inability to 
dorsiflex or plantarflex the foot due to weakness and spasticity, also known as foot drop (Ward, 
2011). An individual with foot drop may experience tripping or falling while walking due to the 
lack of muscular activation in the foot. This risk decreases the individual’s ability to function 
independently and perform activities many associate with daily life. Notably, foot drop interferes 
with the individual’s ability to independently function in their home and/or community (Perry, 
Garrett, Gronley, & Mulroy, 1995). Foot drop causes early onset of fatigue, muscle weakness, 
and reduced balance that are attributed to the hemiplegia (Bulley et al., 2015), which can prevent 
the individual from being mobile in their community and home, further hindering their quality of 
life. 
   Another common symptom in individuals who had a CVA is spasticity (Watkins, et al., 
2002). Spasticity is caused by deficits in voluntary control of muscles resulting in continuous 
contraction of affected muscles (Watkins et al., 2002).  This could be a result of disturbance in 
locomotor skills that aid in neural feedback mechanisms between the peripheral nervous system 
(PNS) and the central nervous system (CNS) (Belda-Lois et al., 2011). A CVA may affect the 
COMPARISON OF FES DEVICE VERSUS AFO BRACE & DAILY LIVING 8 
 
connection between the PNS and CNS, inhibiting the neural feedback an individual may have 
while controlling the movement of their arm, hand, foot and/or ankle, and muscle contraction in 
the arm and leg. This lack of neural feedback may result in spasticity of the muscle, forcing the 
muscle to continuously contract. This can cause pain and discomfort throughout the muscle, 
making it difficult to walk (Ward, 2012). Ward (2012) reviewed the pathophysiology and onset 
of post-CVA spasticity and found that while there is no universal definition of spasticity, the 
pathophysiology occurs when the CNS becomes hyperactive and the motor neuron response to 
sensory input is disintegrated (Ward, 2011). As such, spasticity occurs in the muscle of the side 
most affected from CVA due to the miscommunication of feedback. This involuntary activation 
affects the individual’s quality of life by limiting their ability to partake in ADLs (Ward, 2012).   
Rehabilitative Therapies 
Common rehabilitative therapies to aid in physical deficits include exercises for handling 
curbs, stairs, and ramps as well as getting in and out of a car (Perry et al., 1995). Likewise, 
locomotor skills are retrained as they are often affected when an individual survives a CVA 
(Flansbjer, Holmback, Downham, Pattern, & Lexell, 2005).  
AFO 
To help with foot drop and spasticity, physical rehabilitation devices such as ankle foot 
orthosis (AFO), wheelchairs, and canes are used as the first solution. An individual experiencing 
foot drop and spasticity may be more prone to trip and fall requiring an AFO, which is an 
assistive device recommended to individuals who have experienced a CVA and present the 
physical deficit of foot drop (Nolan &Yarossi, 2011). AFO is a brace that wraps around the calf 
and ankle and extends underneath the foot strapping in the lower part of the leg securing it into a 
90 degree angle (See Appendix F). The AFO helps the individual clear the ground during swing 
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phase to prevent the foot and ankle from rolling when the patient is walking.  AFOs have been 
known to improve mobility as well as improving the quality of life indirectly in individuals with 
CVA (Carse, Bowers, Meadows, & Rowe, 2011).  
There are two types of AFOs; metal and thermoplastic. Metal AFOs are most common 
for individuals with CVA with severe spasticity (Cakar et al., 2010).  Thermoplastic AFOs are 
preferred by individuals with CVA due to their appearance and weight; a thermoplastic AFO is 
lighter than a metal AFO. Cakar et al. (2010) determined the differences in outcomes between 
the different kinds of AFO by measuring the balance and walking ability in individuals with 
CVA. Sixty-one participants were asked to perform various physical tasks in the Berg Balance 
Assessment (Berg, Wood-Dauphnee, Williams, and Maki, 1989), a physical test that measures 
balance, pattern of walking, and fall risk while walking with a thermoplastic AFO. In addition, 
participants were asked to continue to wear the AFO at home while doing their walking 
activities. Cakar et al. (2010) found that wearing a thermoplastic AFO improved balance and 
reduced fall risk (Cakar et al., 2010). Limitations of using an AFO include lack of ankle 
mobility, muscle weakness due to using the brace often, appearance of brace, and lack of shoes 
able to fit around the brace (Bulley et al., 2015).  
FES 
Even though the most common rehabilitative tool for managing foot drop is an AFO, 
there are new devices that have yielded promising results to manage foot drop and increase 
quality of life such as Functional Electrical Stimulation devices (Bulley et al., 2015).  A 
Functional electrical stimulation (FES) device is an alternative approach to treat foot drop by 
electrically stimulating the damaged nerve in the leg (Walkaide, 2019). FES first emerged as an 
alternative treatment option for individuals with a CVA in 1978 (Sabut et al. 2011; Yan, Hui-
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Chan, & Li, 2005).  The FES device stimulates the dorsiflexor muscle of the foot when the foot 
is in the swing phase (Walkaide, 2019) (See Appendix E). The electrical stimulation of the 
dorsiflexor muscle may prevent the individual from tripping and falling. Prior research has found 
that FES usage increases natural gait pattern, improves stability, and provides confidence in 
walking in individuals with CVA (Walkaide, 2019). Sabut et al. (2011) investigated the effects 
of changes in walking ability with FES device therapy with standard of care versus with only 
standard of care. Sabut et al. (2011) found that participants who participated in FES therapy 
combined with standard of care therapy showed improvements in motor functions in participants 
with foot drop than with standard of care therapy alone. In a 12-week time period, participants in 
the FES with standard of care group achieved dorsiflexor strength of 75% versus those in the 
standard of care group who only achieved 27% of strength. Moreover, participants in the 
combination therapy group exhibited a reduction in plantar flexion spasticity thus allowing the 
gastrocnemius and soleus muscle to relax after staying in a contracting position preventing the 
individual from lifting his/her foot in neutral position. FES has also been attributed with 
beneficial walking effects with improvements in walking ability and voluntary muscle control 
(Everaert, Thompson, Su Ling Chong, & Stein, 2010).  FES is used to stimulate the peripheral 
nerve by increasing the motor-potential and providing a carry-over effect where once the FES 
device is turned off, the affected leg continues to walk as if it is stimulated. This effect continues 
the momentum for some time shortly after the use of FES (Everaert et al., 2010). The long-term 
effect of FES used on a regular basis for longer than 3 months has shown improvements in 
corticospinal connectivity in the motor cortex (Everaert et al., 2010). FES as an alternative 
therapy has not only led to improved walking ability and stability but also to an increase in 
confidence in individuals with a CVA (Sabut et al., 2011).  
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The Present Study 
This present study investigated the effect of utilizing two footdrop therapies (FES device 
and AFO brace) on individuals who have experienced a CVA and the impact a CVA has on the 
participant’s activities of daily living (ADL).  A CVA can be thought of as a quick but life 
altering event that may have lasting effects physically, cognitively, and/or psychosocially.  
The Stroke Impact Scale  
In order to assess the effect of foot drop and spasticity on ADLs, a specific questionnaire 
can be utilized; the Stroke Impact Scale (SIS). The questionnaire is CVA specific, patient centered, 
and has a range of domains such as cognition, mobility, and association in society (Lin et al., 
2010). Because of this range in domains, changes of symptoms can be determined over time (Lin 
et al., 2010). Previous research has found that the SIS 3.0 had good test-retest reliability, internal 
consistency, and construct validity (Carod-Artal, Coral, Trizotto, & Moreira, 2008). The SIS also 
had less of a ceiling and floor effect and was more valid, reliable, and sensitive to change compared 
to other quality of life questionnaires (Lai et al., 2002; Duncan et al., 1999).  The SIS 3.0 was also 
sensitive to detect changes in responses in ADLs between 3 and 6 months in individuals who had 
a moderate CVA (Duncan et al., 1999).  For this reason, the present study utilized the SIS.  The 
present study examined the effect of utilizing a FES device versus AFO, and the psychosocial 
impact on individuals who had a CVA at baseline and 6-months.  
Hypothesis. This present study investigated two kinds of physical devices used in current 
practice for rehabilitation and the potential effect they may have on the activities of daily living 
based on the participants’ responses on the SIS. The hypothesis for this study is the participants 
will score higher on the ADL questions when utilizing a FES device than participants using an 
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AFO device because the FES device’s compact aesthetic and application of electrical stimulation 
helps the individual to perform daily tasks independently to a higher degree.   
Material and Methods  
Participants 
 This study was approved by the Montclair State University Institutional Review 
Board and the Kessler Foundation Institutional Review Board. Participants were recruited via 
cold calling from a database called Subject Information Management System (SIMS) at Kessler 
Foundation. SIMS is an encrypted database that converts participants’ information into codes. 
Only Kessler Foundation employees have access to this database thus ensuring confidentiality of 
personal health information (PHI). After the participants were screened and consented, 68 
participants participated in the study (53 males, 15 females; Mage=65.3 years old; SDage=11.1 
years; age range: 39-86) (Refer to Table 1 in Appendix A). 12 participants were excluded from 
the study due to medical reasons that prevented them from completing the study and as a result, 
56 participants finished the study.  
To qualify for the study, participants must have had a history of a CVA that occurred at 
least 90 days ago, have had weakness on one side of his/her body, have had foot drop, were not 
currently using the WalkAide system or any electrical stimulation device for assistance with 
walking. They must have not participated in inpatient or outpatient rehabilitation within the last 
30 days, for CVA, heart disease, lung disease or other physical condition that affected his/her 
ability to walk. They must also have been eligible for Medicare or Medicare Choice/Advantage 
benefits at the time of consent, not have had a heart attack within the last 90 days, not had a stent 
placed in his/her coronary arteries or any other artery in the last 90 days, not had major 
orthopedic surgery (hip, knee or ankle joint replacement) within the last 90 days, not had a 
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coronary artery bypass surgery or a heart valve replacement within the last 6 months. They must 
have been able and willing to comply with study procedures, including follow-up requirements, 
and be willing and able to give informed consent, be able to walk at least 10 meters (about 10 
yards) with or without an assist device, have a walking speed within acceptable range (x < 0.8 
m/s), show ankle lift movement when tested by electrical stimulation, think clearly enough to 
accurately complete the evaluation tests and to correctly use the assist device he/she was 
assigned. Lastly, they must have undergone a neurological assessment by the study physician 
within 30 days before he/she starting the study.   
The participant must NOT have had a history of a seizure disorder, currently have clinical 
electrical stimulation devices (for example: ICD, Pacemaker, Spinal Stimulation,TENS), botox 
injections in the past 6 months in the upper and lower extremity, and have had changes to an 
internal device for management of CVA muscle symptoms (for example: baclofen pump) in the 
last 3 months. They must not have ankle joint weakness, not related to his/her CVA, ankle, foot, 
or knee weakness that requires additional bracing or support for balance, difficulty walking 
safely with the study device, decreased sensation in his/her lower leg that would affect his/her 
ability to walk or participate in study procedures, have skin irritation or lesion on his/her lower 
leg that would limit study participation, or have any underlying medical conditions that would 
limit study participation. They must not have muscle problems that would limit study 
participation and require additional bracing, have pain due to CVA that would limit study 
participation, have difficulty with his/her breathing that would limit his/her study participation, 
moderate or severe heart disease. Lastly, they must not have depression that would limit or 
interfere with study procedures, have a life expectancy less than 12 months or have enrolled or 
participated in another research study that is likely to affect participation in this research study. 
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Design 
 The present study used a mixed design comparing time (Baseline vs. 6 months) 
and treatment (FES device vs. AFO), where time was within subject groups and treatment was 
between groups. The primary dependent variable was the participants’ responses on ADL 
questions on the SIS questionnaire. The secondary dependent variables were the participants’ 
response on SIS questionnaire questions of Strength, Hand Function, Mobility, Communication, 
Emotion, Memory and thinking, and Participation in social roles 
Materials 
This study used Walkaide, an FES device and an AFO brace. The Walkaide was 
developed by Neurotronics Inc. (WalkAide, Innovative Neurotronics, Austin, TX, United States). 
The WalkAide device uses surface electrodes in a single cuff located on the tibia about the 
peroneal nerve to stimulate during the swing phase of the gait cycle to produce the desired 
dorsiflexion during gait. The AFO brace was a custom brace that was molded to the participant’s 
affected shin, ankle, and foot. The custom AFO was created by a fitting clinician. There were 25 
participants in the FES group (17 male, 8 female) and 31 participants in the AFO group (21male 
and 5 female) (See Table 1). 
10 Meter Walk Test: Participants were asked to walk at their normal speed within a walk 
frame of 10 meters. The length of the test was 10 meters however, participants’ time was 
recorded between 8 meters following the International Classification of Functionality, Disability, 
and Health (ICF) code for walking short distances. Participants were asked to perform two 
walks. 
Modified Emory Functional Ambulation Profile:  Participants were asked to perform five 
tasks to assess overall ambulation. These tasks included a five-meter walk on a hard surface, a 
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five meter walk on a carpeted surface, rising from a chair, walking for three meters around an 
object and sitting back down in the chair, walking over obstacles, and walking up and down 
stairs.  
GaitRite Data Capture: Participants were asked to walk six times over an electronic mat 
that assessed their foot pattern and timing via sensors underneath the mat. The data from the 
sensors were recorded through the GaitRite software program on the computer that was 
connected to the mat through USB cables. 
Berg Balance Assessment: Participants were asked to perform 14 tasks that evaluated 
their balance. Each item had a scale of 1-4, 1 “being cannot perform independently therefore 
requiring complete use of physical help” and 4 “being can perform independently without the use 
of physical help.” The highest total score a participant can receive is 56. The scoring range was 
as follows: balance impairment score of 0-20, moderate functioning balance 21-40, and high 
functioning balance 41-56. 
6 Minute Walk Test: Participants were asked to walk for six minutes. This test evaluated 
the participant’s walking distance, which was reflected as an example of performing ADLs in 
participants with foot drop as well as a response to the device the participant was randomly 
assigned to use. The length of the test was about 100 feet long. Participants performed this test 
self-paced and were allowed to take breaks during the test if needed however, the stopwatch 
continued. The data was recorded at certain time intervals of every 30 seconds and recorded on 
the case report form (CRF) until the stopwatch reached six minutes. The results of analyses 
comparing the physical performance between the FES device and AFO brace can be found in 
Bethoux et al (2014) and (2015) for long term follow up. 
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SIS: The SIS is a self-report questionnaire that consisted of nine questions regarding 
mobility around the home and community, physical deficits that may have occurred due to the 
CVA, mood, ability to communicate with others, typical activities during the day, using the most 
affected hand, ability to participate in daily life, memory, and lastly, from 0-100 how much has 
the individual recovered since the CVA. Each main question had a series of sub-questions where 
a participant answered using a 5-point Likert scale; 5 being the highest (depending on the 
question) to 1 being the lowest (depending on the question). While it is not a part of the eight 
categories, there is a ninth question in the form of a rating scale regarding recovery based upon 
how much the participant feels they have recovered since the CVA on a scale from 0-100 (See 
Appendix B). 
The psychometrics of the SIS questionnaire are similar in style and layout of each item 
and responsiveness. The SIS is a questionnaire with 59 items in 8 domains including strength, 
hand function, ADL/IADL, mobility, communication, emotion, memory/thinking, and 
participation in social roles, in addition to a question regarding recovery (Duncan et al., 1999; 
Lin et al., 2010). The SIS questionnaire has Likert scales where responses are based on a 5-point 
scale with 5 being strongly disagree, 4 disagree, 3 neither agree nor disagree, 2 agree, and 1 
strongly agree (Lin et al., 2010).  
 Procedure 
At screening, participants were evaluated based upon history and current medications, 
past medical events (i.e., hospitalizations, surgeries), CVA classification including type of stroke 
(ischemic or hemorrhagic), date of injury, time since stroke, and affected side as well as 
inclusion/exclusion criteria, demographics, and gait speed evaluation in which participants 
performed the 10-meter walk test and their times were recorded. In order to qualify for the study, 
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participants’ times had to be less than 0.8 m/s. This process occurred 30 days prior to enrollment 
in the study. Following consenting, participants were randomly assigned to one of two groups, 
either the Walkaide group or AFO group. Participants were then asked to return another day for 
Walkaide and/or AFO fitting by a trained clinician. Participants in the Walkaide group were 
properly fitted with the Walkaide device on the area of the leg that would receive and react the 
most to the stimulation. Participants in the AFO group had one of their legs scanned or casted in 
order to make a custom orthotic. Participants were required to return for three visits to the 
Kessler Foundation after consenting to participate in the study (one fitting visit and two testing 
sessions; baseline and 6-month follow-up). After the fitting session, the participants participated 
in the baseline data collection where the participants were asked to participate in the following 
assessments; 10 meter walk test, Modified Emory Functional Ambulation Profile, GaitRite Data 
Capture, Berg Balance Assessment, six minute walk test, and self-report questionnaires Stroke 
Impact Scale (SIS). The baseline visit took about an hour to complete all required tasks. After the 
baseline visit, participants were asked to take the device home and use the device as much as 
possible throughout the day. There was no limit to how many times the participant could wear 
the FES device or AFO per day. After 6 months of device usage the participants returned for a 
follow-up data collection. The Follow-up visit included the same tasks as conducted at the 
baseline visit. The 6-month follow-up visit also took about an hour to complete all required 
tasks.  
Analysis 
A two (Treatment: Walkaide and AFO) x two (Time: Baseline versus Six months) mixed 
design ANOVA was used to analyze the average scores of each 8 dependent variables of items 
from the SIS; Strength, Hand Function, Memory and Thinking, Emotions, Communication, 
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Activities of Daily Living, Mobility, and Participation Role Thinking. ADLs items were a 
primary dependent variable analyzed in this study for the effect of treatment usage at pre and 
post time period for overall change in responses on the SIS. The dependent variables were tested 
by calculating the average score of each section. 
Results 
Descriptive Statistics 
The two (Treatment: Walkaide and AFO) x two (Time: Baseline versus Six months) 
mixed design ANOVA descriptive statistics are presented in Tables 1 and 2. The results indicate 
the genders and ages of the participants in the study as well as the number of participants in each 
group in the study.  
Response Averages from the SIS 
There was no significant main effect of Time on responses of Strength items F(1, 51) = 
1.597, p = 0.212. There was no significant main effect of Treatment on responses of Strength 
items F(1, 51) = 0.707, p = 0.404. There was no interaction between Treatment and Time on 
responses of  Strength items F(1, 51) = 0.103, p = 0.750. Figure 1 shows group means of 
Strength responses utilizing Walkaide device was not statistically significantly different than 
utilizing an AFO (see Table 3).   
There was no significant main effect of Time on responses of Hand function items F(1, 
51) = 2.776, p = 0.102. There was no significant main effect of Treatment on responses of Hand 
Function items F(1, 51) = 0.532, p = 0.469. There was no interaction between Treatment and 
Time on responses of Hand Function items F(1, 51) = 0.096, p = 0.758.(see Figure 2). 
There was no significant main effect of Time on responses of Activities of Daily 
Living/Independent Activities of Daily Living (ADL/IADL) items F(1, 51) = 0.004, p = 0.952. 
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There were no significant main effect of Treatment on responses of ADL/IADL items F(1, 51) = 
0.213, p = 0.647. There was no interaction between Treatment and Time on responses of 
ADL/IADL items F(1, 51) = 1.097, p = 0.300.  (see Figure 3). 
There was no significant main effect of Time on responses of Mobility items F(1, 51) = 
0.938, p = 0.337. There was a significant main effect of Treatment on responses of Mobility 
items F(1, 51) = 6.445, p = 0.014. There was no interaction between Time and Treatment on 
responses of Mobility items F(1, 51) = 0.337, p = 0.564.  
There was no significant main effect of Time on responses of Communication items F(1, 
51) = 0.000, p = 0.993. There was no main effect of Treatment on responses of Communication 
items F(1, 51) = 0.439, p = 0.510. There was no interaction between Time and Treatment on 
responses of Communication items F(1, 51) = 1.447, p = 0.235.  
There was no significant main effect of Time on responses Emotion items F(1, 51) = 
0.492, p = 0.486. There was no significant main effect of Treatment on responses Emotion items 
F(1, 51) = 0.018, p = 0.895. There was no interaction between Time and Treatment on responses 
Emotion items F(1, 51) = 0.106, p = 0.746.  
There was no significant main effect of Time on responses of Memory and Thinking 
Participation items F(1, 51) = 0.007, p = 0.935. There was no significant main effect of 
Treatment on responses of Memory and Thinking Participation items F(1, 51) = 0.000, p = 
0.998. There was no interaction between Time and Treatment on responses of Memory and 
Thinking Participation items F(1, 51) = 0.075, p = 0.785.  
There was no significant main effect of Time on responses of Participation Role and 
Thinking items F(1, 51) = 2.454, p = 0.123. There were no significant main effects of Treatment 
on responses of Participation Role and Thinking items F(1, 51) = 0.140,  p = 0.710. There was 
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no interaction between Time and Treatment on responses of Participation Role and Thinking 
items F(1, 51) = 0.510,  p = 0.479.  
Discussion 
The purpose of this study was to determine whether utilizing the Walkaide device or 
AFO brace positively impacts psychosocial factors in individuals with CVA, more importantly 
ADLs. It was hypothesized that utilizing the Walkaide device would yield a positive increase in 
psychosocial outcomes, in particular, ADLs. The benefits of this device is to improve 
individual’s walking, which can help improve stability, increase ambulation, and thus, improve 
participation in activities of daily living. 
The hypothesis was not supported. Instead, CVA participants’ responses on the SIS were 
neither impacted positively nor negatively by wearing a Walkaide device or AFO brace 
compared to either device or to baseline. Bethoux et al. (2014) found a similar result when 
comparing FES device with AFO. In six months, they found the use of FES device was 
noninferior to the use of AFO in gait speed, SIS composite score, and safety (Bethoux et al., 
2014). However, in this present study, at baseline, each subject had a different total score when 
all eight sections from the SIS were summed up resulting in a difference of scores thus not 
establishing a true baseline across all subjects utilizing either a FES device or AFO brace (Please 
refer to Appendix D). Due to this difference already presented at baseline, this effect may have 
also been exhibited at 6-months (Please refer to Appendix D). Therefore, the 8 domains on the 
SIS questionnaire may not be significant suggesting that between baseline and six months, 
wearing an FES device or AFO does not impact the participant’s psychosocial being. 
Furthermore, it does not affect the participant’s ADLs.  
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 FES device is a novel device that has yielded encouraging results in physical therapy for 
individuals with CVA but very little on how the quality of life of individuals who have survived 
a CVA has changed. Therefore, the premise of the present study was to investigate whether or 
not it did yield positive changes in responses on the SIS from baseline to 6-months. With that 
said, the results suggest that wearing an FES device is neither superior nor inferior to wearing an 
AFO. 
Limitations  
A main limitation found in this study was that the SIS was a self-report questionnaire. 
The responses are largely from the point of view of the participant thus, the responses are based 
upon perception and may not be objectively accurate. Therefore, the SIS is more subjective than 
objective.  
Future Research  
Due to the results being derived from responses from the participants’ views, researchers 
should also administer the SIS to caretakers. By administering the SIS to both the CVA patient 
and the caretaker, the researchers would be able to compare the patient’s view of how the CVA 
affected them and the caretaker’s view of how the CVA has affected them. A study conducted by 
Pindus et al. (2018) found that majority of caregivers, whether a family member or nurse, felt ill 
prepared and pressured in knowing how to care for an individual who had a CVA (Pindus et al., 
2018). This lack of knowledge is a barrier of the proper care needed for the individual to recover 
therefore, for future research, investigators should administer the SIS questionnaire to the 
caregivers as well since they play a direct role in the CVA individual’s life and recovery.   
Conclusion 
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Little is still known about the cause of a CVA and how to overcome deficits resulting 
from a CVA. While much of the CVA research continues to investigate advancements for 
physical and cognitive rehabilitation, psychosocial factors are neglected. Therefore, future 
research should take into account the effect a CVA has on the individual’s ADLs because 
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Table 1: Descriptives - Statistics of Gender in each Treatment group (Walkaide or AFO) 
at Baseline and Six month time points.  
 
Time 
Baseline 6 Months 
Male Female Male Female 
WA 17 8 17 8 
AFO 23 5 23 5 
 
Table 2: Descriptives - Average Age and Standard Deviation as a Function of Gender in 
each Treatment group (Walkaide or AFO) at Baseline and Six months. The cut off for each age 
group was 66 years old as shown in the table.  
 
Treatment 
  WA 𝑥𝑥 SD (±) AFO 𝑥𝑥 SD (±) 
BL 
Male 
Under 66 12.00 51.16 1.00 12.00 57.50 0.99 
 Over 66 5.00 75.20 0.99 11.00 75.55 0.99 
BL 
Female 
Under 66 3.00 51.33 1.01 4.00 54.75 0.99 
 Over 66 5.00 72.20 0.99 1.00 72.00 1.00 
6M 
Male 
Under 66 12.00 51.16 1.00 12.00 57.50 0.99 
 Over 66 5.00 75.20 0.99 11.00 75.55 0.99 
6M 
Female 
Under 66 3.00 51.33 1.01 4.00 54.75 0.99 
 Over 66 5.00 72.20 0.99 1.00 72.00 1.00 





Stroke Impact Scale. A CVA-specific self-report rating instrument that measures CVA-
related behaviors (Duncan et al., 1999). These include:  
1. mobility in and around the home or community,  
2. physical problems as a result of the CVA,  
3. questions about memory and thinking,  
4. changes in mood and feelings,  
5. ability to communicate with others,  
6. activities done during a typical day,  
7. ability to use the affected hand, 
8. ability to participate in activities that are meaningful.  
Scoring 
Total help - Couldn’t do it at all - Strongly agree     1 
A lot of help - A lot of trouble - Moderately agree   2 
Some help - Some trouble - Neither agree nor disagree  3 
A little help - A little trouble - Moderately disagree  4 



















Table 3: Group means of responses on Strength as a function of Treatment (Walkaide 




 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 2.79 0.109 2.94 0.172 
AFO 2.66 0.139 2.75 0.166 
 
 
Table 4: Group means of responses on Hand Function as a function of Treatment 





 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 2.54 0.289 2.44 0.270 
AFO 2.23 0.295 2.16 0.280 
 
 
Table 5: Group means of responses on ADL/IADL as a function of Treatment (Walkaide 





 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 3.98 0.128 4.03 0.116 
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Table 6: Group means of responses on Mobility as a function of Treatment (Walkaide 





 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 3.96 0.109 4.06 0.108 
AFO 4.33 0.102 4.35 0.091 
 
Table 7: Group means of responses on Communication as a function of Treatment 





 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 4.53 0.101 4.44 0.157 




Table 8: Group means of responses on Emotion as a function of Treatment (Walkaide 





 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 3.51 0.109 3.43 0.114 
AFO 3.47 0.065 3.44 0.0.80 
 
Table 9: Group means of responses on Memory and Thinking as a function of Treatment 
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Memory and Thinking 
  
Time 
 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 4.48 0.128 4.47 0.151 




Table 10: Group means of responses on Participation Role and Thinking as a function of 
Treatment (Walkaide device or AFO) and Time (Baseline and 6 months).  
 
Participation role and Thinking 
  
Time 
 Baseline 6 Months 
 𝑥𝑥 Error 𝑥𝑥 𝑥𝑥 Error 𝑥𝑥 
WA 3.91 0.151 4.00 0.135 
































Figure 1: Group means and Standard of error for Strength responses as a function of 






Figure 2: Group means and Standard of error of Hand Function responses as a function 






























































Means of Hand Function Responses
Walkaide AFO
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Figure 3: Group means and Standard of error from Activities of Daily Living/ 
Independent Activities of Daily Living (ADL/IADL) responses as a function of Treatment 








Figure 4: Group means and Standard of error from Mobility responses as a function of 



























































Means of Mobility Responses
Walkaide AFO
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Figure 5: Group means and Standard of error from Communication responses as a 








Figure 6: Group means and Standard of error from Emotion responses as a function of 
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Figure 7: Group means and Standard of error from Memory and Thinking role responses 
as a function of Treatment (Walkaide or AFO) and Time (Baseline and 6 months).  
 
          
 
 
Figure 8: Group means and Standard of error from Participation Role and Thinking 
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Figure 9: An image of the use of the Functional Electrical Stimulation (FES) device and 






Figure 10: An image of the device itself and the placement of the device on the 
participants’ upper leg, just below the knee. 
 











Figure 11: An image of the molding of the Ankle Foot Orthosis (AFO) brace that was 
custom made for the participant and fitted by a clinician.  
 
 
 
 
 
 
